---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-018583"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2025-10-20T23:59:59+00:00"
generated_at: "2026-05-17T03:20:21.406569+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# AIM ImmunoTech furnishes investor presentation for Maxim Growth Summit 2025

## Summary
- Presentation furnished for Maxim Growth Summit 2025 taking place Oct 22-23, 2025 in New York.
- No material new financial or operational data disclosed; presentation contains forward-looking statements.
- Highlights Ampligen development for viral diseases, cancers, and immune-deficiency disorders.
- Filing states information is furnished, not filed, and not incorporated by reference.

## SEC filing metadata
- accession: 0001493152-25-018583
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2025-10-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000149315225018583/0001493152-25-018583-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000149315225018583/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-018583
- JSON: https://secwatch.observer/filing/0001493152-25-018583.json
- Plain text: https://secwatch.observer/filing/0001493152-25-018583.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.